Mon, January 27, 2025
Sun, January 26, 2025

Jim Cramer Says J. M. Smucker (SJM) Can't 'Overrun Sentiment' Amid Weight Loss Drugs Threat

  Copy link into your clipboard //business-finance.news-articles.net/content/202 .. run-sentiment-amid-weight-loss-drugs-threat.html
  Print publication without navigation Published in Business and Finance on by MSN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Stocks to Buy or Sell. In this article, we are going to take a look at where The J. M. Smucker Company (NYSE:SJM) stands against other stocks to buy and sell highlighted in Jim Cramer's latest calls.
Jim Cramer, host of CNBC's "Mad Money," discussed the challenges facing J.M. Smucker (SJM) due to the rising popularity of weight-loss drugs like Ozempic and Wegovy. These drugs, which reduce appetite, are impacting food companies by potentially decreasing demand for their products. During a segment on "Squawk on the Street," Cramer highlighted that while J.M. Smucker has a diverse portfolio including pet food, coffee, and snacks, the overarching market sentiment towards food companies is negative due to this new health trend. He noted that despite the company's efforts to diversify, the sentiment driven by the weight-loss drug phenomenon is too strong for J.M. Smucker to easily overcome, suggesting that the stock might continue to face headwinds in the near term.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/other/jim-cramer-says-j-m-smucker-sjm-can-t-overrun-sentiment-amid-weight-loss-drugs-threat/ar-AA1xTzz4 ]